Navigation Links
BD Completes Acquisition of Accuri Cytometers, Inc.
Date:3/18/2011

FRANKLIN LAKES, N.J., March 18, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global technology company, today announced the completion of its acquisition of Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers.

The acquisition expands BD's presence into the emerging affordable personal flow cytometer space, and helps expand the use of flow cytometry technology by researchers in regions of the world where ease of use and affordability are critical.

"The acquisition of Accuri Cytometers complements and broadens BD's offerings for life scientists by making flow cytometry more accessible to a wider audience of scientists and clinicians," said William Rhodes, President, BD Biosciences. "This includes researchers in scientific disciplines that have not traditionally used flow cytometry, such as environmental sciences, microbiology and marine biology."

The financial impact of the acquisition on fiscal year 2011 earnings has been incorporated into the guidance BD provided during its earnings call on February 8, 2011.

About BDBD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world.  BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, c
'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.
2. Assured Pharmacy Completes Audit of 2008-2009 Financial Statements
3. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
4. Samplify Systems Completes Series B Funding
5. Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio
6. Amgen Completes Acquisition of BioVex
7. MicroConstants Completes Installation of Latest LC/MS/MS Technology to Achieve Improved Sensitivity in Bioanalytical Method Development
8. Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional
9. DJO Incorporated Completes Business Integration and Changes Name to DJO Global, Inc.
10. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
11. Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Millar, Inc. , a leader in catheter-based and wireless ... Craig Thummel , President/CEO and member of the ... the Company. The Company also announced its leadership succession ... Management team as his successors. The Board of Directors ... Sales and Marketing, as President, and also a member ...
(Date:6/30/2015)... CENTER VALLEY, Pa. , June 30, 2015 ... designing and delivering innovative solutions for medical and ... it is guaranteeing next-day replacements for surgical equipment ... surgical product manufacturer to offer this type of ... an Olympus Full Service Agreement earlier this year. ...
(Date:6/30/2015)... , June 30, 2015  Ardelyx, Inc. (NASDAQ: ... gastrointestinal and metabolic diseases, today announced that the Company ... 2015, from 8:00 a.m.- 1:00 pm EDT in ... The Ardelyx senior management team will present an overview ... tenapanor, which has completed Phase 2b clinical trials for ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2
... - Novel, ... 15 Carrington,Laboratories, Inc. (Nasdaq: CARN ) today ... toxicology studies of its,GelVac(TM) nasal powder influenza vaccine, incorporating ... a critical step during the vaccine,development and will assess ...
... N.C., Aug. 16 Cancer patients fraught with,flare-ups ... some assistance,in the form of a new easy-to-use ... to quickly deliver pain medication. Cancer patients ... Persistent cancer pain is characterized as continuous pain,present ...
Cached Medicine Technology:Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine 2Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine 3Novel Technology Breaks Through Cancer Pain 2
(Date:6/30/2015)... ... June 30, 2015 , ... On June 26, 2015, Harper’s Bazaar ... five triggers that most people would not expect to cause acne flare-ups. ... primary causes of acne are clogged pores and bacteria and each of ...
(Date:6/30/2015)... New York, New York (PRWEB) , ... June ... ... Xarelto lawsuits ( http://www.xareltolawsuit2015.com/ ) currently pending in a federal multidistrict litigation now ... when the Court convenes its next monthly Status Conference. According to the Court’s ...
(Date:6/30/2015)... ... ... U.S. Women's National Soccer Team will face the Costa Rica Women's National team in ... at Heinz Field in Pittsburgh at 1:30 p.m. local time. On Wednesday, August 19th, ... The USA WNT previously played at Heinz Field in Pittsburgh and won against Iceland by ...
(Date:6/30/2015)... ... June 30, 2015 , ... An opinion piece published ... transfer procedures had over breast implants when reconstructing breasts after a mastectomy. The ... and feel natural,” have increased sensation, and are less likely than implant reconstructions ...
(Date:6/30/2015)... ... 30, 2015 , ... LifeAID Beverage Company has announced that ... dedicated to raising worldwide awareness of the burgeoning “adaptive” movement, I AM ADAPTIVE ... official charity of FitAID. I AM ADAPTIVE is a non-profit whose goal is ...
Breaking Medicine News(10 mins):Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3Health News:USA vs. Costa Rica Tickets at Heinz Field in Pittsburgh and Finley Stadium in Chattanooga: Ticket Down Slashes Presale Ticket Prices for Costa Rica vs. USA WNT 2Health News:Recent Article Advocating for Breast Reconstruction with Fat Transfers Successfully Outlines the Advantages of Transfer Procedures, Notes Beverly Hills Physicians 2Health News:Recent Article Advocating for Breast Reconstruction with Fat Transfers Successfully Outlines the Advantages of Transfer Procedures, Notes Beverly Hills Physicians 3Health News:LifeAID Beverage Company Partners With The Adaptive Movement 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 3
... Health authorities in Vietnam confirmed Wednesday the possibility that a ... could have contracted the lethal H5N1 strain of the bird ... ,A fresh outbreak of bird flu has hit ... lethal H5N1 strain after being hospitalized in serious condition. ...
... humanity, Cuban President Fidel Castro called for governments of the ... ,The non-profit exercise of medicine is capable of ... broadcast Tuesday by the island's mass media. ,In ... in Great Britain, which can shoot down lethal Tomahawk missiles ...
... tea is far better than drinking water, researchers said. ... or more cups of tea can reduce the risk of ... Ruxton from King's College London, it is a wrong belief ... than water as it contains antioxidants. It does not dehydrate ...
... to control a new outbreak of avian flu at three ... Wednesday. ,Laboratory tests confirmed the presence of ... humans, at three farms in Chak Shehzad, where about 12,000 ... the Agriculture and Livestock Ministry. ,There were no ...
... has found that combination asthma therapy, SYMBICORT leads ... (HRQL) and greater patient-reported satisfaction with asthma ... placebo). ,SYMBICORT is a recently approved, ... of asthma in patients 12 years of age ...
... the World Conservation Union (IUCN) has said that a sixth ... ,Unless the trend is reversed, conservationists fear that the ... target of halting biodiversity loss by 2010. ,Of ... western Russia, some 15 percent are classed as 'vulnerable' or ...
Cached Medicine News:Health News:Combo Therapy may Be Highly Beneficial in Asthma Control 2Health News:One-sixth of Europe's Mammals Face Extinction, Warns Conservation Experts 2
... determines osmolality at room temperature with the ... get are cryoscopic artifacts due to high ... interfere with freezing point determinations. The superbly ... Vapro osmometer has a much broader range ...
Rapid assay, results in 1 hours,Range 20-800 ng/mL; sensitivity 2.5 ng/mL,Can be used for animal sera; requires extraction protocol and steroid free serum...
... IMMULITE 2000 assays are ... the IMMULITE 2000, a ... immunoassay analyzer. IMMULITE 2000 ... centralization, and a rapidly ...
... in specimen radiography. The XPERT represents a research ... of gray in every digital x-ray image, thus ... density that heretofore were lost to the human ... x 2 to 8 x 8 in size, ...
Medicine Products: